ArticleFrontiers in oncology2022

PD-L1 expression, tumor mutational burden, and immune cell infiltration in non-small cell lung cancer patients with epithelial growth factor receptor mutations.

Tiantian Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.